218 368

Cited 0 times in

Clinical pattern and outcome of gastric cancer patients with skeletal metastases

Other Titles
 뼈전이를 동반한 위암환자의 임상양상 및 예후 
Authors
 박형순 
Department
 Dept. of Internal Medicine (내과학교실) 
Issue Date
2010
Description
Dept. of Medicine/석사
Abstract
[한글]

[영문]BACKGROUND: Skeletal metastasis is an adverse prognostic factor in gastriccancer, with a rapidly deteriorating clinical course and quality of life. However,current data provide only limited information about it. Herein we evaluated theclinical manifestations and prognostic factors, and treatment outcomes ofgastric cancer patients with skeletal metastasis at diagnosis or during treatment.METHODS: We retrospectively reviewed the patients treated between January1998 and May 2008 in Yonsei University Health System. Radiographs ofspecific bones were taken to diagnose skeletal metastases after an abnormalbone scan or because of clinical symptoms such as pain or paralysis.Radiologists who had no knowledge of the results of any other radiologic orbiochemical examinations interpreted the radiographs.RESULTS: We identified skeletal metastasis in 203 (2.4%) of 8,633 patients;126 patients (62%) had skeletal metastasis at diagnosis (synchronous), andremaining 77 patients developed metastasis during follow-up (metachronous).The median time to skeletal metastasis was 16 months (range, 4 to 87 months).Most patients (n=180, 89%) demonstrated metastasis involving multiple bonesand the spine (86%) was most frequent site. Six patients (3%) developedskeletal metastasis-related events (SRE): Three suffered pathologic fractures,one developed paralysis, and two developed hypercalcemia.As for treatment, 120 patients (59%) received chemotherapy, with or withoutradiotherapy, and remaining 83 received local (radio)therapy or supportive careonly. The median survival time after skeletal metastasis was 103 days (95% CI,80-126 days).Multivariate analysis revealed that elevated ALP [> 158 IU/L; Relative risk(RR)=2.00, p<0.001] and poor performance status [ECOG 3-4; RR=2.11,p=0.003] implied a poor prognosis. For patients who had none or only one ofthese adverse factors identified, chemotherapy had a beneficial effect(p<0.0001).CONCLUSION: This is the first study to investigate the factors that predictsurvival in gastric cancer patients with skeletal metastasis. We recommend thattherapy for gastric cancer with skeletal metastasis be tailored to the adversefactors of each patient in order to extend survival and improve the quality of life
Files in This Item:
T011500.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 2. Thesis
Yonsei Authors
Park, Hyung Soon(박형순)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/125308
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links